Global Health Watch, now in its fourth edition, is widely perceived as the definitive voice for an alternative discourse on health and healthcare. It covers a range of issues that currently impact on health, including the present political and economic architecture in a fast-changing and globalized world; a political assessment of the drive towards Universal Health Coverage; broader determinants of health, such as gender-based violence and access to water; stories of struggles, actions and change; and a scrutiny of a range of global institutions and processes. It integrates rigorous analysis, alternative proposals and stories of struggle and change to present a compelling case for a radical transformation of the way we approach actions and policies on health.
In a brief, clear and easily accessible way, this summary illustrates the dynamics of the obesity epidemic and its impact on public health throughout the WHO European Region, particularly in eastern countries. It describes how factors that increase the risk of obesity are shaped in different settings, such as the family, school, community and workplace. It makes both ethical and economic arguments for accelerating action against obesity, and analyses effective programs and policies in different government sectors, such as education, health, agriculture and trade, urban planning and transport. The summary also describes how to design policies and programs to prevent obesity and how to monitor progress, and calls for specific action by stakeholders: not only government sectors but also the private sector - including food manufacturers, advertisers and traders - and professional consumers' and international and intergovernmental organizations such as the European Union.
Children and young people with developmental disabilities are a large and growing population. But across the world, children and young people with development disabilities have been neglected in services and policy provisions for health and continue to experience stigma, barriers to participation, widespread health inequalities and premature mortality. The aim of this report is to increase awareness of the public health significance of developmental disabilities and the need for increased investment and accountability at all levels. It proposes priority actions to accelerate individual-, family-, community-, and society-level changes to achieve inclusion and health equity.
For over a decade, Global Health Watch has been the definitive source for alternative analysis on health. This new edition addresses the key challenges facing governments and health practitioners today, within the context of rapid shifts in global governance mechanisms and the UN’s Sustainable Development Goals. Like its predecessors, it challenges conventional wisdom while pioneering innovative new approaches to the field. Collaboratively written by academics and activists drawn from a variety of movements, research institutions and civil society groups, it covers some of the most pressing issues in world health, from the resurgence of epidemic diseases such as Ebola to the crisis in the WHO, climate change and the ‘war on drugs’. Combining rigorous analysis with practical policy suggestions, Global Health Watch 5 offers an accessible and compelling case for a radical new approach to health and healthcare across the world.
WHO's annual World Health Statistics reports present the most recent health statistics for the WHO Member States. All reports are available for download in Adobe PDF and excel when applicable at http://www.who.int/gho/publications/world_health_statistics/en/.
With a goal of establishing enduring leadership and commitment for the health of refugees and migrants, WHO, the International Organization for Migration (IOM), the United Nations High Commissioner for Refugees (UNHCR) and Morocco co-organized the Third Global Consultation on the Health of Refugees and Migrants in Rabat, Morocco, on 13–15 June 2023, and led to the adoption of the Rabat Declaration. The Third Global Consultation aimed to strengthen high-level political commitment with an aim to improve, protect and preserve the health and wellbeing of refugees, migrants and host communities. This report captures the summary of key points from this event which includes the need for political commitment, and consideration of equity, inclusion, mainstreaming and accountability. Emphasis was placed on meaningful refugee and migrant participation, effective and equitable access to health care, tackling the social determinants of health and the importance of adopting data- and research-driven approaches.
This study seeks to reinforce the understanding of the interplay between the distinct policy domains of health, trade and intellectual property, and of how they affect medical innovation and access to medical technologies. The second edition comprehensively reviews new developments in key areas since the initial launch of the study in 2013.
H1N1 ("swine flu"), SARS, mad cow disease, and HIV/AIDS are a few examples of zoonotic diseases-diseases transmitted between humans and animals. Zoonotic diseases are a growing concern given multiple factors: their often novel and unpredictable nature, their ability to emerge anywhere and spread rapidly around the globe, and their major economic toll on several disparate industries. Infectious disease surveillance systems are used to detect this threat to human and animal health. By systematically collecting data on the occurrence of infectious diseases in humans and animals, investigators can track the spread of disease and provide an early warning to human and animal health officials, nationally and internationally, for follow-up and response. Unfortunately, and for many reasons, current disease surveillance has been ineffective or untimely in alerting officials to emerging zoonotic diseases. Sustaining Global Surveillance and Response to Emerging Zoonotic Diseases assesses some of the disease surveillance systems around the world, and recommends ways to improve early detection and response. The book presents solutions for improved coordination between human and animal health sectors, and among governments and international organizations. Parties seeking to improve the detection and response to zoonotic diseases-including U.S. government and international health policy makers, researchers, epidemiologists, human health clinicians, and veterinarians-can use this book to help curtail the threat zoonotic diseases pose to economies, societies, and health.
The Global Oral Health Status Report reviews the most recent data on major oral diseases, risk factors and health system challenges and opportunities for reform. The report also introduces the first-ever country oral health profiles with key health and oral health information for each WHO Member State. The report’s clear conclusion is the status of global oral health is alarming and requires urgent action. The report will serve as a reference for policymakers and an orientation for a wide range of stakeholders across different sectors to guide advocacy towards better prioritization of oral health in global, regional and national contexts
WHO recognizes that artificial intelligence (AI) holds great promise for pharmaceutical development and delivery. However, AI also presents risks and ethical challenges that must be addressed if societies, health systems and individuals are to fully reap its benefits. This discussion paper examines the expanding application of AI to each step of development and deployment of medicines and vaccines. AI is already used in most steps of pharmaceutical development, and, in the future, it is likely that nearly all pharmaceutical products that come to market will have been “touched” by AI at some point in their development, approval or marketing. Although these uses of AI may have a commercial benefit, it is imperative that use of AI also has public health benefit and appropriate governance.
World Health Report 2007 discusses the challenges to global health security by the increasing and constant movement around the world of people and products. It looks at the potential of new tools for collective defence, particularly the revised International Health Regulations (2005) which came into force this year. Significantly, the revised Regulations move away from a focus on passive barriers at airports, seaports and borders to a strategy of proactive risk management - detecting an event early and stopping it at its source - before it has a chance to become an international threat.
The Strategic Framework for enhancing control and achieving elimination of human-to[1]human transmission of mpox (2024-2027) is a guide to Member States on the next phase of the global mpox response and to enhance preparedness for future outbreaks. During the public health emergency of international concern (PHEIC) for the global mpox outbreak (July 2022-May 2023), the WHO supported Member States in taking action to stop the outbreak of mpox. In the transition from emergency to long-term response, WHO now recommends that all countries develop and implement plans for mpox control and the elimination of person-to-person transmission of this infectious disease, while continuing to ensure mitigation of zoonotic transmission. This strategic framework supports the development of these strategies.
Pandemic prevention and preparedness are at the top of everyone’s mind as the world continues to tackle the COVID-19 pandemic. During this time, however, the threats posed by the silent pandemic of antimicrobial resistance to human, animal, and plant health, food production, and the environment have not ceased and are steadily growing. More than ever before, we know that addressing the interlinked and multi-faceted challenges posed by antimicrobial resistance requires that we work together – across sectors, government, academic disciplines, civil society, the private sector, and the multilateral system – to advance a One Health approach. This strategic framework on antimicrobial resistance represents an important milestone in the decades-long history of collaboration between the Tripartite organizations - a collaboration that now is even stronger as a result of our close engagement with the United Nations Environment Programme. The framework sets out for the first time what our organizations – as leaders in the multilateral system on the human, animal, plant, and environmental health – will do jointly to support countries’ efforts to scale up national responses to antimicrobial resistance. Countries and partners are strongly encouraged to replicate and amplify the One Health approach used in the framework, based on their own contexts and needs.
Neglected tropical diseases (NTDs) afflict more than 1.4 billion people, many of whom live on less than $1.25 a day. While there are effective ways to manage NTDs, policy-makers and funders have only recently begun to recognize the economic and public health importance of controlling NTDs. The IOM's Forum on Microbial Threats held a workshop September 21-22, 2010, to discuss the science of and policy surrounding NTDs.
On June 13â€"14, 2018, the National Academies of Sciences, Engineering, and Medicine convened a multistakeholder workshop to examine the transitions affecting global health and innovative global health solutions. The goal of bringing these two topics together was to collectively explore models for innovative partnerships and private-sector engagement with the potential to support countries in transition. This publication summarizes the presentations and discussions from the workshop.
Social justice is a matter of life and death. It affects the way people live, their consequent chance of illness, and their risk of premature death. We watch in wonder as life expectancy and good health continue to increase in parts of the world and in alarm as they fail to improve in others.
The World health statistics report is the World Health Organization's (WHO) latest annual compilation of health and health-related indicators for its 194 Member States. The 2023 edition consolidates data for 50+ health and health related indicators (SDGs and GPW13).
1. Introduction and methods of work.-- 2. Alcohol: equity and social determinants.-- 3. Cardiovascular disease: equity and social determinants.-- 4. Health and nutrition of children: equity and social determinants.-- 5. Diabetes: equity and social determinants.-- 6. Food safety: equity and social determinants.-- 7. Mental disorders: equity and social determinants.-- 8. Neglected tropical diseases: equity and social determinants.-- 9. Oral health: equity and social determinants.-- 10. Unintended pregnancy and pregnancy outcome: equity and social determinants.-- 11. Tobacco use: equity and social determinants.-- 12. Tuberculosis: the role of risk factors and social determinants.-- 13. Violence and unintentional injury: equity and social determinants.-- 14. Synergy for equity.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.